biohack.The longevity wire
LIVE WIREUpdated · scanning every 6 hours
12:01 A daily pill for male hair loss passed its second big trial, maker says✦12:15 A popular longevity supplement didn’t slow Parkinson’s in a large trial✦12:04 Drugmakers say Ozempic-style drugs slowed lab measures of aging✦12:03 Gene therapy that aims to make eye cells act younger is tried in 3 people✦15:22 Alzheimer's drug tested in healthy people to see if it can prevent disease✦15:12 AI-designed lung drug made patients' blood look younger on 6 aging tests✦14:54 One-time brain gene therapy for Huntington's is sent for US, UK approval✦12:01 A daily pill for male hair loss passed its second big trial, maker says✦12:15 A popular longevity supplement didn’t slow Parkinson’s in a large trial✦12:04 Drugmakers say Ozempic-style drugs slowed lab measures of aging✦12:03 Gene therapy that aims to make eye cells act younger is tried in 3 people✦15:22 Alzheimer's drug tested in healthy people to see if it can prevent disease✦15:12 AI-designed lung drug made patients' blood look younger on 6 aging tests✦14:54 One-time brain gene therapy for Huntington's is sent for US, UK approval
← People to follow
Alex Zhavoronkov
Photo: World Economic Forum, CC BY 3.0, via Wikimedia Commons
PERSON TO FOLLOW

Alex Zhavoronkov

Founder and co-CEO, Insilico Medicine

Founder and co-CEO of Insilico Medicine, a company that uses generative AI to find drug targets and design drug molecules. He was the lead author of the 2026 Nature Biotechnology study that applied six blood-protein aging clocks to Insilico's lung-fibrosis drug rentosertib.

ai drug discoveryaging clocksbiological agefibrosis

WHAT TO WATCHWhether Insilico tests rentosertib's effect on aging measures in larger, longer trials or in people without lung disease.

ON THE WIRE

Every story about Alex’s work.

Profile sources

  1. 1
    Six Different Aging Clocks Agree: This AI-Designed Drug Turns Back Biological Age ScienceAlert
  2. 2
    Nature Biotechnology | Insilico’s AI-driven IPF candidate rentosertib shows potential for biological age reversal, as assessed by six proteomic aging clocks EurekAlert!
  3. 3
    Drug developed for lung disease may slow biological aging in surprising ‘bonus’ Fox News
  4. 4
    Insilico Medicine AI Drug Rentosertib Cuts Biological Age on Six Independent Protein Clocks Tech Times